1,414 results on '"Tybjaerg-Hansen, Anne"'
Search Results
202. Genetically Elevated Apolipoprotein A-I, High-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease
203. Lipoprotein(a) as a cardiovascular risk factor: current status
204. C-reactive protein and all-cause mortality—the Copenhagen City Heart Study
205. Penetrance of NOD2/CARD15 genetic variants in the general population
206. C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study
207. Genetically Reduced Soluble Epoxide Hydrolase Activity and Risk of Stroke and Other Cardiovascular Disease
208. Surfactant Protein-B 121ins2 Heterozygosity, Reduced Pulmonary Function, and Chronic Obstructive Pulmonary Disease in Smokers
209. Alcohol Intake, Alcohol Dehydrogenase Genotypes, and Liver Damage and Disease in the Danish General Population
210. Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
211. Hepatic Lipase, Genetically Elevated High-Density Lipoprotein, and Risk of Ischemic Cardiovascular Disease
212. Triglycerides, Depression, and Risk of Ischemic Stroke—Reply
213. Genetically Elevated C-Reactive Protein and Vascular Disease
214. ABCA1 Gene Mutations, HDL Cholesterol Levels, and Risk of Ischemic Heart Disease
215. Pentanucleotide Repeat Polymorphism, Lipoprotein(a) Levels, and Risk of Ischemic Heart Disease
216. Common and Rare Alleles in Apolipoprotein B Contribute to Plasma Levels of Low-Density Lipoprotein Cholesterol in the General Population
217. Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis
218. Cardiovascular risk factors are associated with venous thromboembolism
219. Nonfasting Triglycerides and Cardiovascular Risk
220. Hemochromatosis genotypes and risk of 31 disease endpoints: Meta-analyses including 66,000 cases and 226,000 controls
221. Polymorphisms in Apolipoprotein B and Risk of Ischemic Stroke
222. C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
223. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease
224. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
225. Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
226. Genetically Increased Antioxidative Protection and Decreased Chronic Obstructive Pulmonary Disease
227. Combined Analysis of Six Lipoprotein Lipase Genetic Variants on Triglycerides, High-Density Lipoprotein, and Ischemic Heart Disease: Cross-Sectional, Prospective, and Case-Control Studies from the Copenhagen City Heart Study
228. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study
229. Polymorphism in APOB Associated with Increased Low-Density Lipoprotein Levels in Both Genders in the General Population
230. Factor V Leiden Homozygosity, Dyspnea, and Reduced Pulmonary Function
231. Re: Integrin β3 Leu33Pro Homozygosity and Risk of Cancer
232. Hemochromatosis mutations in the general population: iron overload progression rate
233. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population
234. Factor V Leiden and Venous Thromboembolism
235. Single nucleotide polymorphism in the low-density lipoprotein receptor is associated with a threefold risk of stroke: A case-control and prospective study
236. Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population
237. Re: Integrin β3 Leu33Pro Homozygosity and Risk of Cancer
238. Nose and Blood Pressure
239. Integrin β3 Leu33Pro Homozygosity and Risk of Cancer
240. Integrin [[beta].sub.3] Leu33Pro homozygosity and risk of cancer
241. Change in Lung Function and Morbidity from Chronic Obstructive Pulmonary Disease in α1-Antitrypsin MZ Heterozygotes: A Longitudinal Study of the General Population
242. Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease
243. Angiotensinogen Mutations and Risk for Ischemic Heart Disease, Myocardial Infarction, and Ischemic Cerebrovascular Disease: Six Case–Control Studies from the Copenhagen City Heart Study
244. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion
245. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha(sub 1)-antitrypsin MZ heterozygotes: a longitudinal study of the general population
246. Additional file 5: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals
247. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
248. Additional file 2: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals
249. Additional file 1: of Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals
250. Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.